Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey
Abstract
Share and Cite
LeVasseur, N.; Stober, C.; Ibrahim, M.; Gertler, S.; Hilton, J.; Robinson, A.; McDiarmid, S.; Fergusson, D.; Mazzarello, S.; Hutton, B.; Joy, A.A.; McInnes, M.; Clemons, M. Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey. Curr. Oncol. 2018, 25, 305-310. https://doi.org/10.3747/co.25.3911
LeVasseur N, Stober C, Ibrahim M, Gertler S, Hilton J, Robinson A, McDiarmid S, Fergusson D, Mazzarello S, Hutton B, Joy AA, McInnes M, Clemons M. Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey. Current Oncology. 2018; 25(4):305-310. https://doi.org/10.3747/co.25.3911
Chicago/Turabian StyleLeVasseur, N., C. Stober, M. Ibrahim, S. Gertler, J. Hilton, A. Robinson, S. McDiarmid, D. Fergusson, S. Mazzarello, B. Hutton, A.A. Joy, M. McInnes, and M. Clemons. 2018. "Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey" Current Oncology 25, no. 4: 305-310. https://doi.org/10.3747/co.25.3911